The Association Between Sleep Disturbances and Perceived Stress in Substance Use Disorder Treatment

References (67)

1. Babson KA, Boden MT, Harris AH, et al. Poor sleep quality as a risk factor for lapse following a cannabis quit attempt. J Subst Abuse Treat. 2013;44(4):438–443. PubMed CrossRef
2. Bolla KI, Lesage SR, Gamaldo CE, et al. Sleep disturbance in heavy marijuana users. Sleep. 2008;31(6):901–908. PubMed CrossRef
3. Brower KJ, Aldrich MS, Robinson EA, et al. Insomnia, self-medication, and relapse to alcoholism. Am J Psychiatry. 2001;158(3):399–404. PubMed CrossRef
4. Brower KJ, Perron BE. Prevalence and correlates of withdrawal-related insomnia among adults with alcohol dependence: results from a national survey. Am J Addict. 2010;19(3):238–244. PubMed CrossRef
5. Chakravorty S, Chaudhary NS, Brower KJ. Alcohol dependence and its relationship with insomnia and other sleep disorders. Alcohol Clin Exp Res. 2016;40(11):2271–2282. PubMed CrossRef
6. Hu N, Ma Y, He J, et al. Alcohol consumption and incidence of sleep disorder: a systematic review and meta-analysis of cohort studies. Drug Alcohol Depend. 2020;217:108259. PubMed CrossRef
7. Huhn AS, Finan PH. Sleep disturbance as a therapeutic target to improve opioid use disorder treatment. Exp Clin Psychopharmacol. 2022;30(6):1024–1035. PubMed CrossRef
8. Vrajová M, Šlamberová R, Hoschl C, et al. Methamphetamine and sleep impairments: neurobehavioral correlates and molecular mechanisms. Sleep. 2021;44(6):zsab001. PubMed
9. Rady A, Mekky J, Moulokheya T, et al. Polysomnographic correlates for the risk of relapse in detoxified opiate-misuse patients. Neuropsychiatr Dis Treat. 2020;16:3187–3196. PubMed
10. Mukherjee D, Stankoski DM, Tilden SE, et al. Reregulation of cortisol levels and sleep in patients with prescription opioid use disorder during long-term residential treatment. Drug Alcohol Depend. 2021;227:108931. PubMed CrossRef
11. Erga AH, Nesvåg S, Dahlberg IE, et al. Persistent sleep problems among people in recovery from substance use disorders: a mixed methods study. Addict Res Theor. 2022;30(6):422–430.
12. Koob GF, Colrain IM. Alcohol use disorder and sleep disturbances: a feed forward allostatic framework. Neuropsychopharmacology. 2020;45(1):141–165. PubMed CrossRef
13. Dunn KE, Huhn AS, Bergeria CL, et al. Non-opioid neurotransmitter systems that contribute to the opioid withdrawal syndrome: a review of preclinical and human evidence. J Pharmacol Exp Ther. 2019;371(2):422–452. PubMed
14. Gates P, Albertella L, Copeland J. Cannabis withdrawal and sleep: a systematic review of human studies. Subst Abus. 2016;37(1):255–269. PubMed CrossRef
15. Plazzi G, Montagna P, Meletti S, et al. Polysomnographic study of sleeplessness and oneiricisms in the alcohol withdrawal syndrome. Sleep Med. 2002;3(3):279–282. PubMed CrossRef
16. Angarita GA, Emadi N, Hodges S, et al. Sleep abnormalities associated with alcohol, cannabis, cocaine, and opiate use: a comprehensive review. Addict Sci Clin Pract. 2016;11(1):9. PubMed CrossRef
17. Yi CM, Huhn AS, Hobelmann JG, et al. Integration of patient-reported outcomes assessment into routine care for patients receiving residential treatment for alcohol and/or substance use disorder. J Addict Med. 2022;16:e240–e247. PubMed CrossRef
18. Ek J, Jacobs W, Kaylor B, et al. Addiction and sleep disorders. Adv Exp Med Biol. 2021;1297:163–171. PubMed CrossRef
19. Brower KJ, Perron BE. Sleep disturbance as a universal risk factor for relapse in addictions to psychoactive substances. Med Hypotheses. 2010;74(5):928–933. PubMed CrossRef
20. Conroy DA, Arnedt JT. Sleep and substance use disorders: an update. Curr Psychiatry Rep. 2014;16(10):487. PubMed CrossRef
21. Álvarez RP, Daigre C, Ros-Cucurull E, et al. Insomnia at the onset of addiction treatment may be related to earlier relapses: a one-year follow-up study. Eur Psychiatry. 2021;64(suppl 1):S561–S562.
22. Wilkerson AK, Sahlem GL, Bentzley BS, et al. Insomnia severity during early abstinence is related to substance use treatment completion in adults enrolled in an intensive outpatient program. J Subst Abuse Treat. 2019;104:97–103. PubMed CrossRef
23. McEwen BS, Karatsoreos IN. Sleep deprivation and circadian disruption: stress, allostasis, and allostatic load. Sleep Med Clin. 2015;10(1):1–10. PubMed
24. Lo Martire V, Caruso D, Palagini L, et al. Stress & sleep: a relationship lasting a lifetime. Neurosci Biobehav Rev. 2020;117:65–77. PubMed CrossRef
25. Yap Y, Slavish DC, Taylor DJ, et al. Bi-directional relations between stress and self-reported and actigraphy-assessed sleep: a daily intensive longitudinal study. Sleep. 2020;43(3):zsz250. PubMed CrossRef
26. Ruisoto P, Contador I. The role of stress in drug addiction. An integrative review. Physiol Behav. 2019;202:62–68. PubMed CrossRef
27. Goeders NE. The impact of stress on addiction. Eur Neuropsychopharmacol. 2003;13(6):435–441. PubMed CrossRef
28. MacLean RR, Armstrong JL, Sofuoglu M. Stress and opioid use disorder: a systematic review. Addict Behav. 2019;98:106010. PubMed CrossRef
29. Koob GF, Buck CL, Cohen A, et al. Addiction as a stress surfeit disorder. Neuropharmacology. 2014;76 Pt B(0 0):370–382. PubMed CrossRef
30. Brower KJ. Assessment and treatment of insomnia in adult patients with alcohol use disorders. Alcohol. 2015;49(4):417–427. PubMed CrossRef
31. Zhang R, Tomasi D, Manza P, et al. Sleep disturbances are associated with cortical and subcortical atrophy in alcohol use disorder. Transl Psychiatry. 2021;11(1):428. PubMed CrossRef
32. Brower KJ, Krentzman A, Robinson EAR. Persistent insomnia, abstinence, and moderate drinking in alcohol-dependent individuals. Am J Addict. 2011;20(5):435–440. PubMed CrossRef
33. Hartwell EE, Pfeifer JG, McCauley JL, et al. Sleep disturbances and pain among individuals with prescription opioid dependence. Addict Behav. 2014;39(10):1537–1542. PubMed CrossRef
34. Morin CM. Insomnia: Psychological assessment and management. Guilford Press; 1993.
35. Bastien CH, Vallières A, Morin CM. Validation of the Insomnia Severity Index as an outcome measure for insomnia research. Sleep Med. 2001;2(4):297–307. PubMed CrossRef
36. Chiu HY, Chang LY, Hsieh YJ, et al. A meta-analysis of diagnostic accuracy of three screening tools for insomnia. J Psychosom Res. 2016;87:85–92. PubMed CrossRef
37. Cohen S. Perceived stress in a probability sample of the United States. In: Spacapan S, Oskamp S, eds. The Social Psychology of Health. Sage Publications, Inc; 1988:31–67.
38. Lesage FX, Berjot S, Deschamps F. Psychometric properties of the French versions of the perceived stress scale. Int J Occup Med Environ Health. 2012;25(2):178–184. PubMed CrossRef
39. Taylor JM. Psychometric analysis of the ten-item perceived stress scale. Psychol Assess. 2015;27(1):90–101. PubMed
40. Cohen S, Janicki-Deverts D. Who’s stressed? Distributions of psychological stress in the United States in probability samples from 1983, 2006, and 2009. J Appl Social Psychol. 2012;42(6):1320–1334.
41. Dzaja A, Arber S, Hislop J, et al. Women’s sleep in health and disease. J Psychiatr Res. 2005;39(1):55–76. PubMed
42. Baker FC, Driver HS. Circadian rhythms, sleep, and the menstrual cycle. Sleep Med. 2007;8(6):613–622. PubMed CrossRef
43. Ohayon MM, Carskadon MA, Guilleminault C, et al. Meta-Analysis of quantitative sleep parameters from childhood to old age in healthy individuals: developing normative sleep values across the human lifespan. Sleep. 2004;27(7):1255–1273. PubMed CrossRef
44. Vitiello MV. Sleep in normal aging. Sleep Med Clin. 2006;1(2):171–176.
45. Varga AW, Ducca EL, Kishi A, et al. Effects of aging on slow-wave sleep dynamics and human spatial navigational memory consolidation. Neurobiol Aging. 2016;42:142–149. PubMed CrossRef
46. Matud MP. Gender differences in stress and coping styles. Personal Individ Differ. 2004;37(7):1401–1415.
47. Stefaniak AR, Blaxton JM, Bergeman CS. Age differences in types and perceptions of daily stress. Int J Aging Hum Dev. 2022;94(2):215–233. PubMed CrossRef
48. Wang LP, Maxwell SE. On disaggregating between-person and within-person effects with longitudinal data using multilevel models. Psychol Methods. 2015;20(1):63–83. PubMed CrossRef
49. Kleiman E. Understanding and analyzing multilevel data from real-time monitoring studies: an easily-accessible tutorial using R. 2017.
50. R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing; 2023.
51. Bates D, Mächler M, Bolker B, et al. Fitting linear mixed-effects models using lme4. Journal of statistical software. J Stat Softw. 2015;67(1):1–48.
52. Acock A. A Gentle Introduction to Stata. Stata Press; 2014.
53. Nieminen P. Application of standardized regression coefficient in meta-analysis. BioMedInformatics. 2022;2(3):434–458.
54. Cohen J. Statistical power analysis for the behavioral sciences. Academic Press; 2013.
55. Koob GF. The role of CRF and CRF-related peptides in the dark side of addiction. Brain Res. 2010;1314:3–14. PubMed CrossRef
56. Thorne HB, Rockloff MJ, Ferguson SA, et al. Gambling problems are associated with alcohol misuse and insomnia: results from a representative national telephone survey. Int J Environ Res Public Health. 2021;18(13):6683. PubMed
57. Liu H, Zhou Z, Huang L, et al. Prevalence of smartphone addiction and its effects on subhealth and insomnia: a cross-sectional study among medical students. BMC Psychiatry. 2022;22(1):305. PubMed
58. Wei Q, Zhang S, Pan Y, et al. Epidemiology of gaming disorder and its effect on anxiety and insomnia in Chinese ethnic minority adolescents. BMC Psychiatry. 2022;22(1):260–269. PubMed
59. Fazeli S, Mohammadi Zeidi I, Lin CY, et al. Depression, anxiety, and stress mediate the associations between internet gaming disorder, insomnia, and quality of life during the COVID-19 outbreak. Addict Behav Rep. 2020;12:100307. PubMed CrossRef
60. Van Wijk M. An examination of the relationship between insomnia symptoms and treatment outcome in binge eating disorder. Memorial University of Newfoundland; 2019.
61. Reid MJ, Gamaldo CE, Dunn KE, et al. Effects of Suvorexant on sleep-EEG power spectrum in patients undergoing buprenorphine tapered opioid withdrawal. Sleep Med. 2022;100:S210–S211.
62. Arnedt JT, Conroy DA, Brower KJ. Treatment options for sleep disturbances during alcohol recovery. J Addict Dis. 2007;26(4):41–54. PubMed CrossRef
63. Speed TJ, Hanks L, Turner G, et al. A comparison of cognitive behavioral therapy for insomnia to standard of care in an outpatient substance use disorder clinic embedded within a therapeutic community: a RE-AIM framework evaluation. Trials. 2022;23(1):965. PubMed CrossRef
64. Chakravorty S, Vandrey RG, He S, et al. Sleep management among patients with substance use disorders. Med Clin North Am. 2018;102(4):733–743. PubMed CrossRef
65. Geoffroy PA, Lejoyeux M, Rolland B. Management of insomnia in alcohol use disorder. Expert Opin Pharmacother. 2020;21(3):297–306. PubMed CrossRef
66. Fragale JE, James MH, Avila JA, et al. The insomnia-addiction positive feedback loop: role of the orexin system. Front Neurol Neurosci. 2021;45:117–127. PubMed CrossRef
67. James MH, Fragale JE, Aurora RN, et al. Repurposing the dual orexin receptor antagonist suvorexant for the treatment of opioid use disorder: why sleep on this any longer? Neuropsychopharmacology. 2020;45(5):717–719. PubMed CrossRef